Antigen & Antibodies Market

TABLE OF CONTENTS

1 INTRODUCTION 
    1.1 OBJECTIVES OF THE STUDY
    1.2 MARKET DEFINITION
    1.3 MARKET SCOPE
           1.3.1 MARKETS COVERED
    1.4 YEARS CONSIDERED FOR THE STUDY
    1.5 CURRENCY
    1.6 LIMITATIONS
    1.9 STAKEHOLDERS

2 RESEARCH METHODOLOGY 
    2.1 RESEARCH DATA
    2.2 SECONDARY DATA
           2.2.1 KEY DATA FROM SECONDARY SOURCES
    2.3 PRIMARY DATA
           2.3.1 KEY DATA FROM PRIMARY SOURCES
    2.4 MARKET SIZE ESTIMATION
           2.4.1 BOTTOM-UP APPROACH
           2.4.2 GROWTH FORECAST
           2.4.3 TOP-DOWN APPROACH
    2.5 MARKET BREAKDOWN AND DATA TRIANGULATION
    2.6 ASSUMPTIONS FOR THE STUDY

3 EXECUTIVE SUMMARY 

4 PREMIUM INSIGHTS 

5 MARKET OVERVIEW 
    5.1 INTRODUCTION
    5.2 MARKET DYNAMICS
           5.2.1 DRIVERS
           5.2.2 RESTRAINTS
           5.2.3 OPPORTUNITIES
           5.2.4 CHALLENGES
    5.3 PRICING ANALYSIS
    5.4 VALUE CHAIN ANALYSIS
    5.5 SUPPLY CHAIN ANALYSIS
    5.6 ECOSYSTEM ANALYSIS
    5.6 PORTER FIVE FORCES ANALYSIS
    5.8 COVID-19 IMPACT ANALYSIS
    5.9 REGULATORY LANDSCAPE
    5.10 TECHNOLOGY ANALYSIS
    5.11 TRADE DATA ANALYSIS
    5.12 PATENT ANALYSIS

6 ANTIGEN & ANTIBODIES MARKET, BY PRODUCT  
    6.1 INTRODUCTION
    6.2 ANTIBODIES
           6.2.1 INFECTIOUS DISEASE ANTIBODIES
           6.2.2 TUMOR MARKER ANTIBODIES
           6.2.3 CHRONIC AND METABOLIC DISORDER ANTIBODIES
           6.2.4 OTHER ANTIBOIES
    6.3 ANTIGEN
           6.3.1 VIRAL ANTIGEN
           6.3.2 BACTERIAL ANTIGEN
           6.3.3 CARCINOGEN ANTIGEN
           6.3.4 OTHER ANTIGENS

7 ANTIGEN & ANTIBODIES MARKET, BY TECHNIQUES  
    7.1 INTRODUCTION
    7.2 ELISA
    7.3 CLIA
    7.2 IHS
    7.3 IFA
    7.2 RAPID TEST
    7.3 OTHERS

8 ANTIGEN & ANTIBODIES MARKET, BY  
    8.1 INTRODUCTION
    8.2 DISEASE DIAGNOSIS
    8.3 DRUG DISCOVERY AND DEVELOPMENT
    8.4 LIFE SCIENCE RESEARCH
    8.5 OTHERS (IF ANY)

11 ANTIGEN & ANTIBODIES MARKET, BY HEALTHCARE PROVIDERS FACILITIES  
     11.1 HOSPITALS 
     11.2 AMBULATORY CARE CENTERS & CLINICS
     11.3 CLINICAL LABORATORIES 
     11.4 HOME OR SELF TESTING  
     11.5 PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES 
     11.6 RESEARCHERS AND ACADEMIA

12 ANTIGEN & ANTIBODIES MARKET, BY REGION  
     12.1 NORTH AMERICA 
             12.1.1 US
             12.1.2 CANADA
     12.2 EUROPE 
             12.2.1 GERMANY
             12.2.2 UK
             12.2.3 FRANCE
             12.2.4 ITALY
             12.2.5 SPAIN
             12.2.6 REST OF ERUOPE
     12.3 ASIA-PACIFIC
             12.3.1 JAPAN
             12.3.2 CHINA
             12.3.3 INDIA
             12.3.4 REST OF ASIA-PACIFIC
     12.4 LATIN AMERICA 
     12.5 MIDDLE EAST AND AFRICA

13  COMPETITIVE LANDSCAPE 
     13.1 OVERVIEW
     13.2 MARKET SHARE/RANKING ANALYSIS, 2021 (IN TERMS OF % OF USD MILLION)
     13.3 COMPETITIVE SCENARIO
             13.3.1 PRODUCT LAUNCHES AND APPROVALS
             13.3.2 PARTNERSHIPS, COLLABORATIONS, MERGERS, AND AGREEMENTS
             13.3.3 EXPANSIONS
             13.3.4 ACQUISITIONS
             13.3.5 OTHER DEVELOPMENTS
     13.4 COMPETITIVE LEADERSHIP MAPPING (2019)
             13.4.1 STARS
             13.4.2 EMERGING LEADERS
             13.4.3 PERVASIVE
             13.4.4 PARTICIPANTS

14 COMPANY PROFILES 
(Business Overview, Products Offered, Recent Developments, MnM View)*
     14.1 INTRODUCTION
     14.2 BIO RAD LABORATORIES
     14.3 THE NATIVE ANTIGEN COMPANY
     14.4 MICROBIX BIOSYSTEMS INC.
     14.5 CREATIVE DIAGNOSTICS
     14.6 HYTEST
     14.7 AALTO BIO REAGENTS
     14.8 ADVANCED BIOTECHNOLOGIES INC.
     14.9 PROSPEC-TANY TECHNOGENE LTD.
     14.1 ACROBIOSYSTEMS INC.
     14.11 GENWAY BIOTECH INC.
     14.12 BOSTER BIOLOGICAL TECHNOLOGY

*Business Overview, Products Offered, Recent Developments, MnM View might not be captured in case of unlisted companies.

15 APPENDIX 
     15.1 INSIGHTS OF INDUSTRY EXPERTS
     15.2 DISCUSSION GUIDE
     15.3 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
     15.4 AVAILABLE CUSTOMIZATIONS
     15.5 RELATED REPORTS
     15.6 AUTHOR DETAILS